KTRA - Kintara Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Kintara Therapeutics's activity chart (see below) currently has 7 price targets and 9 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 390.67 days.

Most recent stock forecast was given by from MAXIM GROUP on 14-Jul-2023. First documented stock forecast 14-Sep-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Jul-2023

$14

$7.7 (122.22%)

Buy Since 29-Sep-2021

$750000

$749993.69 (11904662.00%)

$300

Buy Since 14-Sep-2020

$250

$243.7 (3868.25%)

Show more analysts

What is KTRA (Kintara Therapeutics) average time for price targets to be met?

On average it took 390.67 days on average for the stock forecasts to be realized with a an average price target met ratio 83.33

Which analyst has the current highest performing score on KTRA (Kintara Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on KTRA (Kintara Therapeutics)?

Jason Mccarthy works at MAXIM GROUP and has 3 price targets and 3 ratings on KTRA

Which analyst is the currently most bullish on KTRA (Kintara Therapeutics)?

Michael King with highest potential upside - $749993.69

Which analyst is the currently most reserved on KTRA (Kintara Therapeutics)?

Jason Mccarthy with lowest potential downside - $7.7